Intersect ENT Inc (XENT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Intersect ENT Inc (XENT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7289
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Intersect ENT Inc (Intersect), formerly Sinexus Inc is a medical device company that offers chronic sinusitis solutions. The company offers steroid releasing implants and mini steroid implants. It provides surgical solutions for patients, disease recurrence with recurrent symptoms. Intersect develops sinus drug delivery technology. Intersect’s products are used in chronic sinusitis treatment such as facial pain or pressure, nasal congestion and obstruction, loss of smell and taste, headache, discolored nasal discharge, loss of sleep and fatigue and depression. The company also develops propel dissolvable sinus drug delivery stent to help open the sinuses. It markets its products in the US and abroad. Intersect is headquartered in Menlo Park, California, the US.

Intersect ENT Inc (XENT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Intersect ENT Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Intersect ENT Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Intersect ENT Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Intersect ENT Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Intersect ENT Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Intersect ENT Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Intersect ENT Raises US$30 Million In Series D Financing 10
Equity Offering 12
Intersect ENT Raises USD103 Million in Public Offering Shares 12
Intersect ENT Raises USD63.3 Million in IPO 14
Intersect ENT Inc – Key Competitors 15
Intersect ENT Inc – Key Employees 16
Intersect ENT Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Financial Announcements 18
Aug 01, 2018: Intersect ENT reports second quarter 2018 results 18
May 01, 2018: Intersect ENT Reports First Quarter 2018 Results 19
Feb 27, 2018: Intersect ENT Reports Fourth Quarter and Full Year 2017 Results 20
Jan 08, 2018: Intersect ENT Reports Preliminary Q4 and Year 2017 Revenue 21
Nov 02, 2017: Intersect ENT Reports Third Quarter 2017 Results 22
Aug 01, 2017: Intersect ENT Reports Second Quarter 2017 Results 23
May 02, 2017: Intersect ENT Reports First Quarter 2017 Results 24
Feb 28, 2017: Intersect ENT Reports Fourth Quarter and Full Year 2016 Results 25
Jan 09, 2017: Intersect ENT Reports Preliminary Q4 and Year 2016 Revenue 26
Corporate Communications 27
Jul 20, 2017: Teresa L. Kline Joins Intersect ENT’s Board of Directors 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Intersect ENT Inc, Medical Equipment, Key Facts, 2017 2
Intersect ENT Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Intersect ENT Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Intersect ENT Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Intersect ENT Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Intersect ENT Inc, Deals By Market, 2012 to YTD 2018 8
Intersect ENT Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Intersect ENT Raises US$30 Million In Series D Financing 10
Intersect ENT Raises USD103 Million in Public Offering Shares 12
Intersect ENT Raises USD63.3 Million in IPO 14
Intersect ENT Inc, Key Competitors 15
Intersect ENT Inc, Key Employees 16

List of Figures
Intersect ENT Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Intersect ENT Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Intersect ENT Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Intersect ENT Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Intersect ENT Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Intersect ENT Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Intersect ENT Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Intersect ENT Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Intersect ENT Inc (XENT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Industrija nafte dd (INA-R-A):企業の財務・戦略的SWOT分析
    Industrija nafte dd (INA-R-A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • China Oilfield Services Ltd (2883):企業の財務・戦略的SWOT分析
    China Oilfield Services Ltd (2883) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Dunelm Group plc (DNLM):企業の財務・戦略的SWOT分析
    Dunelm Group plc (DNLM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Isramco Inc (ISRL):企業の財務・戦略的SWOT分析
    Summary Isramco Inc (Isramco), a subsidiary of Israel Oil Company Ltd, is an oil and gas company that offers exploration, production and development of oil and natural gas properties. The company acquires, explores, develops and produces oil and natural gas resources. It offers services such as work …
  • Gradalis Inc-製薬・医療分野:企業M&A・提携分析
    Summary Gradalis Inc (Gradalis), formerly Murex Pharmaceuticals, is a biopharmaceutical company which focuses on the development and commercialization of therapies for the treatment of cancer. Its developmental pipeline comprises of candidates for various cancer indications which include ovarian, br …
  • National Health Insurance Company – Daman PJSC:企業の戦略・SWOT・財務分析
    National Health Insurance Company – Daman PJSC - Strategy, SWOT and Corporate Finance Report Summary National Health Insurance Company – Daman PJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Amtrust Financial Services, Inc.:企業のM&A・事業提携・投資動向
    Amtrust Financial Services, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amtrust Financial Services, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • KINeSYS Inc.:企業の戦略・SWOT・財務分析
    KINeSYS Inc. - Strategy, SWOT and Corporate Finance Report Summary KINeSYS Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Philogen SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Philogen SpA (Philogen) is a biotechnology company that develops biopharmaceuticals for the treatment of angiogenesis-related disorders. The company provides pipeline products such as darleukin, teleukin, fibromun, radretumab, dekavil and tetravil, among others. It offers technologies such a …
  • Altius Minerals Corporation:企業のM&A・事業提携・投資動向
    Altius Minerals Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Altius Minerals Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Children’s Medical Center:企業の戦略的SWOT分析
    Children's Medical Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Enerkem Inc:企業の戦略的SWOT分析
    Enerkem Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Burwill Holdings Limited:企業のM&A・事業提携・投資動向
    Burwill Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Burwill Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Dong-A Socio Holdings Co Ltd (000640):企業の財務・戦略的SWOT分析
    Dong-A Socio Holdings Co Ltd (000640) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • A.G.Barr p.l.c.:企業の戦略・SWOT・財務情報
    A.G.Barr p.l.c. - Strategy, SWOT and Corporate Finance Report Summary A.G.Barr p.l.c. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Ageas NV:企業の戦略・SWOT・財務情報
    Ageas NV - Strategy, SWOT and Corporate Finance Report Summary Ageas NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Medifast, Inc. (MED):企業の財務・戦略的SWOT分析
    Medifast, Inc. (MED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Fenwal Inc-医療機器分野:企業M&A・提携分析
    Summary Fenwal Inc (Fenwal), a subsidiary of Fresenius Kabi AG is a blood technology company that supports transfusion medicine and cell therapies. The company’s products include amicus separator, blood pack units with whole blood filter, mononuclear cell collection, alyx component collection system …
  • Vifor Pharma AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Vifor Pharma AG (Vifor Pharma) a subsidiary of Galenica Ltd is a healthcare service provider that discovers, develops, manufactures, and commercializes prescription and over the counter pharmaceutical products for the treatment of iron replacement therapy. The company offers products for tre …
  • SK Bioland Co Ltd:企業の戦略・SWOT・財務分析
    SK Bioland Co Ltd - Strategy, SWOT and Corporate Finance Report Summary SK Bioland Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆